Category:News
Pages in category "News"
The following 184 pages are in this category, out of 184 total.
D
G
- Genetic risk of atrial fibrillation. July 12, 2007
- Genetic variability is linked to differences in response to warfarin therapy
- Glycemic index diets: More lentils, less mushy white bread. July 19, 2007
- Gradual decline in mortality rate following STEMI in the United States
- Guidelines: The ESC/ACC/AHA/WHF Global Task Force Releases New Universal Definition of MI
H
- HDB Tirofiban decreases rate of periprocedural myocardial infarction compared to placebo in patients with poor responsiveness to clopidogrel and aspirin: Results of the 3T/2R study
- Heart failure: A1 Adenosine Antagonists for Heart Failure
- Heart Failure: Acoustic Cardiography Improves Clinicians’ Confidence for Making the Diagnosis when BNP is Ambiguous
- Heart Failure: Data wanted on Effective Management Strategies for Patients with HF and PSF
- Heart Failure: Increasing Role of Advanced Practice Nurses in Heart Failure Management
- Heart Failure: Results of CORONA trial released
- Heart muscle cells grown from human embryonic stem cells can help repair damaged hearts following a heart attack. August 30, 2007
- High Dose Diuretics Associated with Adverse Outcomes in ADHERE
- High dose tirofiban and clopidogrel are safe and effective in the ON-TIME-2 trial
- High Dose Tirofiban is similar to Abciximab in reducing Major Adverse Cardiac Events
- High dose Tirofiban Might be Beneficial among Poor Responders to Clopidogrel and Aspirin Following Elective PCI: Results of the 3T/2R study
- High recurrence rate of stent thrombosis after the first event: Results from the Dutch Stent Thrombosis Registry
- High red cell distribution width associated with adverse outcomes in patients with coronary artery disease
- Homocysteine lowering with B vitamins again fails to show benefit
- Hospital-level Mortality Data for MI, CHF Available on Federal Website. June 25, 2007
- How do I submit news article
- Hoy en Medicina: El estudio SALT cuestiona la prevalencia de hiperaldosteronismo primario no diagnosticado en pacientes con hipertension y bajos niveles de renina
I
- Immediate transfer for PCI after fibrinolysis plus abciximab improves outcome in CARESS-in-AMI trial
- Implantation of skeletal myoblasts into scarred myocardium improves symptoms but not heart function
- In vivo imaging of inflammatory cells trafficking to atherosclerotic lesions
- Increased white blood cell count and ventricular remodeling
- Inflammatory biomarkers predict short-term mortality in patients with peripheral arterial disease
- Inhaled anticholinergics for the treatment of COPD is associated with an increased risk of cardiovascular events.
- Insertable Loop Recorder Tracks Cardiac Arrhythmias Following Acute Myocardial Infarction
- Intensified NT BNPguided Therapy might be Beneficial among Patients aged less than 75 Years: Results from the TIME-CHF Trial
- Intensive blood sugar control among diabetics does not increase mortality in the ADVANCE trial
- Intensive blood sugar control is associated with increased mortality among type 2 diabetics in ACCORD
- Intracoronary abciximab is superior to intravenous infusion in reducing infarct size during primary PCI
- Intracoronary infusion of selected and unselected mononuclear cells does not lead to significant improvement in cardiac function after sustained ischemia: Results from the REGENT trial
- Intravenous iron for treatment of anemia in heart failure
- It’s About Time: A Regionalized Approach to Patients with AMI. August 8, 2007
J
L
- Lancet Editor Forsees Wikis as the Future for Medical Journals
- Landmark analysis of the TRITON-TIMI 38 trial demonstrates significant benefit with the loading and maintenance doses of prasugrel
- Larger Versus Smaller Clinical Safety Databases for Regulatory Approval of Drugs.
- LDL Cholesterol and its Association with Cancer: July 24, 2007
- Left main coronary artery disease: which stent type is preferred for off-label PCI?
- Left main stenting is associated with similar rates of death, Q wave myocardial infarction and stroke compared with CABG at 3-year follow-up
- Long Term Adherence to Clopidogrel and Late Adverse Cardiac Events after Off-Label Use of Sirolimus-Eluting Stents: Results of the MATRIX Registry
- Long-term outcomes of off-pump vs. on-pump coronary artery bypass grafts. August 12, 2007
- Loss of adenylyl cyclase gene increases life span and protects the aging heart. August 10th, 2007
- Low-risk Women with Unstable Angina and NSTEMI Might be Better off with Medical Therapy than Invasive Treatment
- LV Remodeling Reversed among Patients with Asymptomatic Systolic Dysfunction with Metoprolol
M
- Making the most of cardiac resynchronization therapy : remotely monitoring patients
- MC-1 does not reduce cardiovascular and cerebrovascular events in phase 3 MEND-CABG II trial
- MC-1 does not reduce cardiovascular and cerebrovascular events in the phase 3 MEND-CABG II trial
- Measuring Fractional Flow Reserve During PCI Improves 1-Year Outcomes
- MEND-CABG II trial does not suggest improved outcomes with the novel drug MC1 in patients undergoing high risk coronary artery bypass surgery
- Metabolic syndrome linked to higher rates of atrial fibrillation
- Metabolic syndrome: Study links soft drink consumption with increased risk of developing metabolic syndrome
- Metoprolol Associated with Lower Rates of Major CV Events in POISE Trial for High Risk Patients Undergoing Noncardiac Surgery
- Microvolt T Wave Alternans Test (MTWA) not Predictive of Ventricular Arrhythias Following MI
- More evidence of the primacy of chest compressions over ventilation in cardiopulmonary resuscitation
- Myeloperoxidase levels shown to predict future cardiovascular risk in healthy individuals. July 11, 2007
N
- Nephrotic syndrome and risk of venous and arterial thromboembolism
- New AHA statement focuses on improving rates and success of bystander CPR
- New AHA statement on hyperglycemia during ACS admissions
- New formula for predicting long-term survival based on exercise treadmill testing
- New guidelines for the management of cocaine chest pain
- New guidelines hope to clarify the role of endomyocardial biopsies
- New meta-analysis demonstrates significant incidence of psychiatric side effects of the weight loss medication rimonabant
- New practice guidelines for use of biomarkers in ACS and heart failure. July 22, 2007
- New randomized comparison of unprotected left main coronary artery stenting and CABG
- New study uses gene variants to predict cardiovascular risk
- New target for treating salt-induced hypertension
- News:NT-proBNP Guided vs. Sympton-Guided Heart Failure Therapy
- NHLBI recommends early termination of the intensive blood sugar lowering strategy in the ACCORD trial
- NOBORI™ stent is non-inferior to Taxus® stents in the NOBORI 1 trial
O
P
- Paclitaxel coated angioplasty balloons are effective in reducing restenosis in the leg
- Paclitaxel eluting stents are safe and effective in diabetic patients compared to bare metal stents
- Panic Attacks in Postmenopausal Women Increase Risk of CV Events
- PCI: Nonclinical factors may influence physician decision-making
- PEPCAD II ISR study suggests that drug eluting balloons are safe and effective compared with drug eluting stents in treating in-stent restenosis
- Percutaneous Coronary Interventions can be performed in centers without on-site cardiac surgical back-up
- Periostin: A possible treatment for heart failure. July 20, 2007
- Pioglitazone Prevents Progression of Coronary Atherosclerosis in Diabetic Patients With Coronary Artery Disease: Results of the PERISCOPE Trial
- Planning your New Year’s resolution—which diet is best?
- Platelet monitoring can improve outcomes following PCI among clopidogrel resistant patients
- Pre Treatment with 600 mg of Clopidogrel does not Improve Outcomes in Stable PCI Patients: PRAGUE-8
- Pre-operative Statin Therapy Improves Clinical Outcomes among Cardiac Surgical Patients: Results from a Meta-Analysis
- Predicting the Mode of Death for Heart Failure Patients. July 29, 2007
- Predicting who will benefit from cardiac resynchronization therapy: results of PROSPECT
- Preoperative statins for prevention of atrial fibrillation following cardiac surgery
- Prevention: Results of the ILLUMINATE Trial Released at AHA 2007
- PRoFESS®, the Largest Recurrent Stroke Prevention Trial Results were Presented at the 17th European Stroke Conference
- Promising results from a phase 2 study of a vaccine for hypertension
- PROVIDENCE-1 trial Results: Rifalazil Has No Effect in Patients with Intermittent Claudication
- Pulmonary embolism is the cause of approximately 10% of hospital deaths despite approved therapies for treatment and prevention. July 26, 2007
R
- Recombinant Human Erythropoietin (rHuEpo): Lack of Effect on Response to ASA or Clopidogrel
- Reductive stress, like its counterpart oxidative stress, can induce cardiomyopathy. August 16th, 2007
- Reloading With Clopidogrel Improves Clinical Outcomes in Patients with Acute Coronary Syndromes: ARMYDA-RELOAD
- Remote ischemic preconditioning may improve clinical outcomes after CABG procedure
- Removal of debris from the coronary arteries does not improve outcomes: Results from the A-F study
- Renin: who needs it, anyway?
- Results from STITCH Trial Demonstrate a Simplified, Step-Care Process is More Effective than Guidelines-Based Practice in Hypertension Treatment
- Rethinking a “healthy weight”: New study finds that being overweight is not associated with increased mortality from cardiovascular causes
- Revascularization with CABG or PCI had no Difference on Outcomes of Death, non-fatal MI, or CVA for Diabetics with Multi-Vessel Coronary Disease: Results of the CARDia Trial
- Rhythm Control Demonstrated as Equally Effective as Rate Control in Preventing CV Mortality
- Rhythm control is no better than rate control among patients with atrial fibrillation and congestive heart failure
- Rimonabant does not reduce atherosclerosis progression in STRADIVARIUS
- RNAPc2 in ACS, Results of ANTHEM-TIMI 32. June 22, 2007
- Rosiglitazone: Twists and Turns on the Road to Clarity Regarding Safety with Rosiglitazone. August 10, 2007
- Rosuvastatin is Not Beneficial Among Patients with Chronic Heart Failure: Results from GISSI-HF trial
- Rosuvastatin reduces coronary artery disease progression over time in the ASTEROID trial
S
- Should beta-Blockers Be Continued for Patients Hospitalized with decompenstated Heart Failure
- Similar nephrotoxic effects with iodixanol and iomeprol in the CONTRAST trial
- Simvastatin and ezetimibe combination does not reduce the rate of progression of aortic valve disease in the SEAS trial
- SPECT Substudy of COURAGE shows Improved Perfusion with PCI at Follow-Up
- Standard Physician Care for Heart Failure is Just as Effective as and Less Expensive Than a Home Monitoring System
- States and Institutions Impose Restrictions on Physician-Industry Relationships
- Statins found to be protective against recurrence of atrial fibrillation after cardioversion
- Statins in Heart Failure: Results of CORONA
- Statins may cause sleep disorders
- Stents: Johnson & Johnson Reports Significant Decrease in Stent Sales
- News:Study demonstrates that non-cardiac cells can help repair a damaged heart; new excitement for existence of cardiac stem cells. August 26, 2007
- Study Examines Use of CD34+ Stem Cells in Advanced CAD Patients
- Study proposes a final common pathway linking smoking, kidney disease, and inflammation to atherogenesis
- Subendocardial Ischemia In Patients with Chest Pain and Normal Coronary Angiograms: A Cardiovascular Magnetic Resonance Study
- Successful PCI for Chronic Total Occlusion of the LAD is Associated with Improved Long-term Survival
- Sunitinib, a small molecular weight tyrosine-kinase inhibitor, is found to have cardiac toxicity
- Susceptibility loci for intracranial aneurysm in European and Japanese populations
- SYNTAX study fails to support PCI as non-inferior to CABG in patients with left main or 3-vessel coronary artery disease
T
- Telmisartan is as effective and safe as ramipril in patients at high risk for vascular events: Results from the ONTARGET trial
- The 2009 SCAI Annual Scientific Sessions is to be held in Las Vegas
- The ASTRAL Trial Demonstrates Angioplasty and Stenting Offer No Benefit Over Medical Therapy in Patients with Renal Arterial Stenoses
- The Couma-Gen Study did not Demonstrate a Reduction in Out-of-range INRs in Patients with Pharmacogenetic-guided Dosing of Warfarin
- The Efficacy of XIENCE V Stent over Taxus Stent Decreases with Time: Results from the SPIRIT II study
- The EVEREST trial suggests MitraClip® for mitral regurgitation is effective
- The GENESIS Trial Demonstrates Disappointing Results With Pimecrolimus Eluting Stents
- The GISSI-HF trial suggests long-term treatment with n-3 PUFAs provides moderate clinical benefits for chronic heart failure patients
- The On-Time 2 trial Suggests Benefit with Early Administration of Tirofiban in the Ambulance following Acute Myocardial Infarction.
- The safety of thiazolidinediones in older diabetics
- Thrombus aspiration in patients with ST elevation myocardial infarction improves mortality at 1 year in the TAPAS trial
- News:Thyroid abnormalities affect more than 30% of males on amiodarone
- Ticagrelor is superior to Clopidogrel in the treatment of patients with acute coronary syndrome with or without ST-segment elevation: Results of the PLATO study
- Time to Abandon Facilitated PCI: Results from the FINESSE trial
- Tirofiban and transfer compares favorably to fibrinolysis in STEMI
- Today In Medicine: European Heart Journal Announces Articles to be Available in Open Source Format
- Today in Medicine: Implanting the Same vs. Different Drug-Eluting Stent (DES) for the Treatment of DES Restenosis.
- Today in Medicine: Judges or Defendants: Should the Journals be the Judges on Conflict of Interest?
- Today in Medicine: Mixed Long-term Results for Sirolimus-Eluting Stent Implantation in Diabetic Patients
- Today in Medicine: NY Times Describes Health and Economic Impact of Ablation for A Fib
- Today in Medicine: SALT study questions prevalence of undiagnosed primary hyperaldosteronism among patients with low-renin hypertension
- Today in Medicine: Study Examines Use of CD34+ Stem Cells in Advanced CAD Patients
- Today in Medicine: Study Shows Favorable Long-Term Outcomes for DES Implantation in Unprotected Left-main Lesions
- Torcetrapib Associated with Higher CV Event Rates in ILLUMINATE
- TRANSCEND Study Misses Primary Endpoint
- TRANSCEND Study suggests that telmisartan reduces cardiovascular events
- Transfusion of blood stored for more than 14 days increases mortality among cardiac surgical patients
- Treatment of hypertension in the very old reduces all-cause mortality
- Treatment of hypertension with indapamide with or without perindopril is beneficial in the elderly: Results from the HYVET study
- Treatment of paroxysmal nocturnal hemoglobinuria with the anti-complement antibody eculizumab helps prevent thromboembolism
- TRITON-TIMI 38 stent analysis demonstrates that prasugrel is better than clopidogrel in reducing the incidence of early and late stent thrombosis
U
- Understanding the stiff heart: scientists discover the cells and molecules responsible for cardiac fibrosis. August 12, 2007
- Underutilization of Cardiac Rehab Despite Guidelines and Reimbursement
- Upstream Pharmacotherapy not Superior to Cath Lab Based Therapy in Primary PCI: Results from the FINESSE Trial
- Use of Epoetin Alpha in Critically Ill Patients. Sept 10th, 2007.
- Use of Epoetin Alpha in Critically Ill Patients. Sept 8th, 2007.
